跳至主要内容
临床试验/NCT00310219
NCT00310219已完成不适用

Comparative Study of Gross Tumor Volume Definition With or Without PET Fusion for Patients With Non-Small Cell Lung Carcinoma

Radiation Therapy Oncology Group4 个研究点 分布在 2 个国家目标入组 52 人开始时间: 2006年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
4
主要终点
The impact of positron emission tomography (PET)/CT fusion planning on lung V20 vs planning with CT scan alone

研究概览

简要总结

RATIONALE: Imaging procedures, such as positron emission tomography (PET) scan and CT scan, may help doctors plan radiation therapy for patients with non-small cell lung cancer.

PURPOSE: This clinical trial is studying how well a combined PET scan and CT scan works compared to a CT scan alone in planning radiation therapy for patients with stage II or stage III non-small cell lung cancer.

详细描述

OBJECTIVES:

Primary

  • Determine the impact of positron emission tomography (PET)/CT fusion scan and CT scan alone, by comparing gross tumor volume (GTV) contours and three-dimensional conformal radiotherapy treatment plans using 2 separate data sets (PET/CT fusion scan and CT scan only), in patients with stage II or III non-small cell lung cancer who are planning to undergo radiotherapy.
  • Determine the impact of PET on GTV (cm^3), number of involved nodes, location of involved nodes, and dosimetric measures of normal tissue toxicity (mean lung dose, V20, and mean esophageal dose).

Secondary

  • Determine the rate of elective nodal failures (nodal failures in regions that are not intentionally irradiated to definitive doses [i.e., ipsilateral hilum, mediastinum, or ipsilateral supraclavicular fossa]).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Histologically or cytologically confirmed non-small cell lung cancer (NSCLC)
  • •Stage IIA/IIB or stage IIIA/IIIB disease
  • •Planning to undergo radiotherapy
  • •Local or regional nodal recurrence after surgery allowed
  • •No malignant pleural effusion
  • •PATIENT CHARACTERISTICS:
  • •Zubrod performance status 0-2
  • •Negative pregnancy test
  • •Not pregnant or nursing
  • •Fertile patients must use effective contraception
  • •PRIOR CONCURRENT THERAPY:
  • •See Disease Characteristics
  • •Concurrent neoadjuvant and/or concurrent chemotherapy allowed
  • •No concurrent intensity-modulated radiotherapy

排除标准

  • 未提供

研究组 & 干预措施

Arm 1

Experimental

Two radiation oncologists are randomly assigned to develop either a 3DCRT plan using CT only, or a 3DCRT plan using fused PET/CT

干预措施: computed tomography (Procedure)

Arm 1

Experimental

Two radiation oncologists are randomly assigned to develop either a 3DCRT plan using CT only, or a 3DCRT plan using fused PET/CT

干预措施: positron emission tomography (Procedure)

结局指标

主要结局

The impact of positron emission tomography (PET)/CT fusion planning on lung V20 vs planning with CT scan alone

时间窗: Two treatment plans are centrally reviewed to determine the difference in lung V20 between the plans

The impact of positron emission tomography (PET)/CT fusion planning on location of involved lymph nodes vs planning with CT scan alone

时间窗: Two treatment plans are centrally reviewed to determine the difference in location of involved lymph nodes between the plans

The impact of positron emission tomography (PET)/CT fusion planning on GTV (cm³) vs. planning with CT scan alone

时间窗: Two treatment plans are centrally reviewed to determine the difference in gross tumor volume between the plans

The impact of positron emission tomography (PET)/CT fusion planning on number of contoured lymph nodes vs. planning with CT scan alone

时间窗: Two treatment plans are centrally reviewed to determine the difference in number of contoured lymph nodes between the plans

The impact of positron emission tomography (PET)/CT fusion planning vs planning with CT scan alone on mean esophagus dose

时间窗: Two treatment plans are centrally reviewed to determine the difference in mean esophagus dose between the plans

次要结局

  • Rate of elective nodal failures as assessed by failure in previously uninvolved regional lymph nodes at 2 years(From registration to 2 years)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验